House concurrent resolution recognizing May 2025 as Progressive Supranuclear Palsy Awareness Month in Vermont
H.C.R. 65 is a House concurrent resolution that recognizes May 2025 as Progressive Supranuclear Palsy (PSP) Awareness Month in Vermont. The resolution describes PSP as a rare, progressive neurological disorder that affects movement, cognition, mood, sleep, and overall quality of life, and notes that it is often mistaken for Parkinson’s disease. It also emphasizes that there is currently no cure or disease-modifying treatment, and that limited public and medical understanding can lead to misdiagnosis and hinder research and clinical trials.
The resolution is primarily commemorative and educational rather than regulatory. It directs the General Assembly to formally recognize the awareness month and asks the Secretary of State to send copies of the resolution to CurePSP and the Vermont Medical Society. Its purpose is to raise public and health care community awareness, support affected families and caregivers, and encourage continued efforts toward better diagnosis, treatment, and ultimately a cure.
This resolution does not change Vermont statutes, create new programs, or impose legal obligations. Its practical effect is symbolic and informational: it places the General Assembly on record in support of PSP awareness and may help promote outreach among health care providers, advocates, patients, and caregivers. The only formal administrative action required is transmission of the resolution to CurePSP and the Vermont Medical Society.
The tone of the resolution is strongly supportive and compassionate. The bill text frames PSP as a serious and under-recognized disease and presents the awareness month as a way to honor patients and families while encouraging greater understanding in the medical community. Because there is no recorded committee testimony or vote history in the provided materials, there is no evidence of opposition or divided sentiment in the available record.
No notable contention is evident in the provided materials. The resolution is noncontroversial in nature, and the available record contains no committee debate, amendments, or votes indicating disagreement. The only implicit policy concern raised in the text is the broader need for improved medical awareness, earlier diagnosis, and research attention for a rare disease, but this is presented as a rationale for the resolution rather than a point of dispute.